Explore more publications!
Yemen Health Report
Got News to Share?

Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

Press releases published on February 13, 2026

Opus Genetics Announces $25 Million Private Placement
5 hours ago

Opus Genetics Announces $25 Million Private Placement

Indeterminate GlobeNewswire
Netramark Announces Uplisting to Toronto Stock Exchange
5 hours ago

Netramark Announces Uplisting to Toronto Stock Exchange

Indeterminate GlobeNewswire
Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging
5 hours ago

Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging

Indeterminate GlobeNewswire
Medicenna Announces Changes to Board Composition
5 hours ago

Medicenna Announces Changes to Board Composition

Indeterminate GlobeNewswire
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET
6 hours ago

ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026, at 8:00 a.m. ET

Indeterminate GlobeNewswire
Nxera Pharma Proposes Changes to its Board of Directors
7 hours ago

Nxera Pharma Proposes Changes to its Board of Directors

Indeterminate GlobeNewswire
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
11 hours ago

Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025

Indeterminate GlobeNewswire
Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals
14 hours ago

Tilray erweitert den pharmazeutischen Zugang im Vereinigten Königreich durch eine strategische Vereinbarung mit Smartway Pharmaceuticals

Indeterminate GlobeNewswire
Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals
14 hours ago

Tilray élargit son accès aux produits pharmaceutiques au Royaume-Uni grâce à un accord stratégique avec Smartway Pharmaceuticals

Indeterminate GlobeNewswire
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
14 hours ago

OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares

Indeterminate GlobeNewswire
InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China
15 hours ago

InnoCare Announces First Patient Dosed in the Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

Indeterminate GlobeNewswire
Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock
15 hours ago

Coherus Oncology, Inc. Announces Pricing of Public Offering of Common Stock

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions